Abveris is a contract lab discovering monoclonal antibodies for reagent and therapeutic purposes. Using proprietary engineered in vivo systems, Abveris delivers hybridomas producing murine mABs to targets that cannot be found in natural in vivo systems.
Delivery of custom-screened monoclonal hybridoma cell lines producing IgG monoclonal antibodies in tight timelines.
The service component is important to us.
The limiting factor in most in vivo antibody discovery platforms is the diversity of the immune response of the host animal. Abveris uses a proprietary rodent that has been engineered to express a more diverse antibody repertoire than regular animals. This enables the discovery of antibodies with specificities that cannot be found in other in vivo systems.
Our specialty! We screen for ideal PK/ADA reagents targeting IgG’s and funky molecules alike. Rapid delivery available.
Rapid discovery of diverse panels of mAbs custom screened to your specifications.
DNA immunization, flow cytometry screening and other options are available.
Devin has nearly 20 years of experience in the immunological sciences with specialties in cellular immunology, molecular immunology, and in vivo research models.
Since moving out of academia Devin has designed and managed antibody discovery campaigns against over 500 targets.
He is a passionate immunologist and father.
Dr. Turner earned his B.S. in Molecular, Cellular, and Developmental Biology from UCLA and Ph.D. in Immunology from the Division of Medical Sciences at Harvard University.
Garren is an antibody enthusiast who has been working on the business side of biotherapeutics development since graduating business school. Garren has managed antibody discovery platforms based on hybridomas, phage display, B-cell sequencing and now hybridomas again.
Garren earned his B.S. in Economics and Finance from Bentley University and is proud to be a new father. He lives with his wife and son in Somerville, MA.
In off time Garren enjoys: fishing, hiking, Ultimate frisbee, mountain biking and camping.